Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

BACKGROUND AND AIMS: Azathioprine [AZA] is recommended for maintenance of steroid-free remission in inflammatory bowel disease IBD. The aim of this study has been to establish the incidence and severity of AZA-induced pancreatitis, an idiosyncratic and major side effect, and to identify specific ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Teich, Niels, Mohl, Wolfgang, Bokemeyer, Bernd, Bündgens, Burkhard, Büning, Jürgen, Miehlke, Stephan, Hüppe, Dietrich, Maaser, Christian, Klugmann, Tobias, Kruis, Wolfgang, Siegmund, Britta, Helwig, Ulf, Weismüller, Joseph, Drabik, Attyla, Stallmach, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692264/
https://www.ncbi.nlm.nih.gov/pubmed/26468141
http://dx.doi.org/10.1093/ecco-jcc/jjv188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692264/
https://www.ncbi.nlm.nih.gov/pubmed/26468141
http://dx.doi.org/10.1093/ecco-jcc/jjv188

Ejemplares similares